AAAAAA

   
Results: 1-25 | 26-34
Results: 1-25/34

Authors: DOWLING TC FRYE RF ZEMAITIS MA
Citation: Tc. Dowling et al., SIMULTANEOUS DETERMINATION OF P-AMINOHIPPURIC ACID, ACETYL-P-AMINOHIPPURIC ACID AND IOTHALAMATE IN HUMAN PLASMA AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical sciences and applications, 716(1-2), 1998, pp. 305-313

Authors: FRYE RF STIFF DD BRANCH RA
Citation: Rf. Frye et al., A SENSITIVE METHOD FOR THE SIMULTANEOUS DETERMINATION OF CAFFEINE ANDITS DIMETHYLXANTHINE METABOLITES IN HUMAN PLASMA - APPLICATION TO CYP1A2 PHENOTYPING, Journal of liquid chromatography & related technologies, 21(8), 1998, pp. 1161-1171

Authors: MURPHY JE AUSTIN ML FRYE RF
Citation: Je. Murphy et al., EVALUATION OF GENTAMICIN PHARMACOKINETICS AND DOSING PROTOCOLS IN 195NEONATES, American journal of health-system pharmacy, 55(21), 1998, pp. 2280-2288

Authors: ADEDOYIN A FRYE RF MAURO K BRANCH RA
Citation: A. Adedoyin et al., CHLOROQUINE MODULATION OF SPECIFIC METABOLIZING ENZYMES ACTIVITIES - INVESTIGATION WITH SELECTIVE 5 DRUG COCKTAIL, British journal of clinical pharmacology, 46(3), 1998, pp. 215-219

Authors: MARX MA FRYE RF MATZKE GR GOLPER TA
Citation: Ma. Marx et al., CEFAZOLIN AS EMPIRIC THERAPY IN HEMODIALYSIS-RELATED INFECTIONS - EFFICACY AND BLOOD-CONCENTRATIONS, American journal of kidney diseases, 32(3), 1998, pp. 410-414

Authors: JOY MS MATZKE GR FRYE RF PALEVSKY PM
Citation: Ms. Joy et al., DETERMINANTS OF VANCOMYCIN CLEARANCE BY CONTINUOUS VENOVENOUS HEMOFILTRATION AND CONTINUOUS VENOVENOUS HEMODIALYSIS, American journal of kidney diseases, 31(6), 1998, pp. 1019-1027

Authors: FRYE RF ADEDOYIN A MAURO K MATZKE GR BRANCH RA
Citation: Rf. Frye et al., USE OF CHLORZOXAZONE AS AN IN-VIVO PROBE OF CYTOCHROME-P450 2E1 - CHOICE OF DOSE AND PHENOTYPIC TRAIT MEASURE, Journal of clinical pharmacology, 38(1), 1998, pp. 82-89

Authors: BURCKART GJ FRYE RF KELLY P BRANCH RA JAIN A FUNG JJ STARZL TE VENKATARAMANAN R
Citation: Gj. Burckart et al., INDUCTION OF CYP2E1 ACTIVITY IN LIVER-TRANSPLANT PATIENTS AS MEASUREDBY CHLORZOXAZONE 6-HYDROXYLATION, Clinical pharmacology and therapeutics, 63(3), 1998, pp. 296-302

Authors: FRYE RF BERTZ RJ GRANNEMAN GR LAUVA I LAMM J DENNIS S VALDES J
Citation: Rf. Frye et al., EFFECT OF RITONAVIR ON CYP1A2, 2C19, AND 2E1 ACTIVITIES IN-VIVO, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 44-44

Authors: ADEDOYIN A TRUMP DL BRUFSKY A FRYE RF HOFACKER J BRANCH RA
Citation: A. Adedoyin et al., SELECTIVE ALTERATION OF SPECIFIC METABOLIZING ENZYME-ACTIVITIES BY DISULFIRAM AND KETOCONAZOLE, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 67-67

Authors: GLEASON PP FRYE RF OTOOLE T
Citation: Pp. Gleason et al., DEBILITATING REACTION FOLLOWING THE INITIAL DOSE OF TRAMADOL, The Annals of pharmacotherapy, 31(10), 1997, pp. 1150-1152

Authors: MARX MA FRYE RF MATZKE GR GOLPER TA
Citation: Ma. Marx et al., CEFAZOLIN FOR EMPIRIC TREATMENT OF HD-RELATED INFECTIONS - EFFICACY AND BLOOD-CONCENTRATIONS, Journal of the American Society of Nephrology, 8, 1997, pp. 939-939

Authors: MATZKE GR FRYE RF
Citation: Gr. Matzke et Rf. Frye, DRUG ADMINISTRATION IN PATIENTS WITH RENAL-INSUFFICIENCY - MINIMIZINGRENAL AND EXTRARENAL TOXICITY, Drug safety, 16(3), 1997, pp. 205-231

Authors: FRYE RF MATZKE GR ADEDOYIN A PORTER JA BRANCH RA
Citation: Rf. Frye et al., VALIDATION OF THE 5-DRUG PITTSBURGH COCKTAIL APPROACH FOR ASSESSMENT OF SELECTIVE REGULATION OF DRUG-METABOLIZING-ENZYMES, Clinical pharmacology and therapeutics, 62(4), 1997, pp. 365-376

Authors: DOWLING TC FRYE RF MATZKE GR FRALEY DS
Citation: Tc. Dowling et al., PAH RENAL CLEARANCE AFTER AN IV BOLUS IS NOT AN ACCURATE MARKER OF ERPF, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 83-83

Authors: DOWLING TC FRYE RF MATZKE GR FRALEY DS RABINOVITZ M
Citation: Tc. Dowling et al., REDUCED ACETYLATION OF PAH IN LIVER-DISEASE, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 84-84

Authors: FRYE RF MATZKE GR SCHADE R DIXON R RABINOVITZ M
Citation: Rf. Frye et al., EFFECTS OF LIVER-DISEASE ON THE DISPOSITION OF THE OPIOID ANTAGONIST NALMEFENE, Clinical pharmacology and therapeutics, 61(1), 1997, pp. 15-23

Authors: FRYE RF STIFF DD
Citation: Rf. Frye et Dd. Stiff, DETERMINATION OF CHLORZOXAZONE AND 6-HYDROXYCHLORZOXAZONE IN HUMAN PLASMA AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical applications, 686(2), 1996, pp. 291-296

Authors: FRYE RF BRANCH RA
Citation: Rf. Frye et Ra. Branch, IMPROVED HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF DEBRISOQUINE AND 4-HYDROXYDEBRISOQUINE IN HUMAN URINE FOLLOWING DIRECT-INJECTION, Journal of chromatography B. Biomedical applications, 677(1), 1996, pp. 178-182

Authors: MATZKE GR FRYE RF JOY MS PALEVSKY P
Citation: Gr. Matzke et al., DETERMINANTS OF CEFTRIAXONE CLEARANCE BY CVVHD AND CVVH, Journal of the American Society of Nephrology, 7(9), 1996, pp. 1359-1359

Authors: MATZKE GR JOY MS FRYE RF PALEVSKY P
Citation: Gr. Matzke et al., CLEARANCE OF CEFTAZIDIME (TAZ) BY CONTINUOUS VENOVENOUS HEMOFILTRATION (CVVH) AND HEMODIALYSIS (CVVHD), Journal of the American Society of Nephrology, 7(9), 1996, pp. 1360-1360

Authors: DOWLING TC FRYE RF MATZKE GR FRALEY DS
Citation: Tc. Dowling et al., RENAL CLEARANCES OF AMINOHIPPURATE AND ITS ACETYLATED METABOLITE IN PATIENTS WITH LIVER-DISEASE, Journal of the American Society of Nephrology, 7(9), 1996, pp. 1653-1653

Authors: FRYE RF MATZKE GR JALLAD NS WILHELM JA BIKHAZI GB
Citation: Rf. Frye et al., THE EFFECT OF AGE ON THE PHARMACOKINETICS OF THE OPIOID ANTAGONIST NALMEFENE, British journal of clinical pharmacology, 42(3), 1996, pp. 301-306

Authors: MATZKE GR FRYE RF ALEXANDER ACM REYNOLDS R DIXON R JOHNSTON J RAULT RM
Citation: Gr. Matzke et al., THE EFFECT OF RENAL-INSUFFICIENCY AND HEMODIALYSIS ON THE PHARMACOKINETICS OF NALMEFENE, Journal of clinical pharmacology, 36(2), 1996, pp. 144-151

Authors: KARARA AH FRYE RF HAYES PE WEAVER ML ROBINSON WT RAULT RM MATZKE GR
Citation: Ah. Karara et al., PHARMACOKINETICS OF ABECARNIL IN PATIENTS WITH RENAL-INSUFFICIENCY, Clinical pharmacology and therapeutics, 59(5), 1996, pp. 520-528
Risultati: 1-25 | 26-34